Antibody responses to SARS-CoV-2 in patients with COVID-19 - Long, Quan-Xin; Liu, Bai-Zhong; Deng, Hai-Jun; Wu, Gui-Cheng; Deng, Kun; Chen, Yao-Kai; Liao, Pu; Qiu, Jing-Fu; Lin, Yong; Cai, Xue-Fei; Wang, De-Qiang; Hu, Yuan; et al. (Nature medicine, 2020)
Keywords: 692/699; 692/699/255; 692/699/255/2514; Adult; Aged; Antibodies; Antibodies, Viral - blood; Antibody Formation - drug effects; Antibody Formation - immunology; Antiviral Agents - therapeutic use; Antiviral drugs; Asymptomatic; Betacoronavirus - genetics; Betacoronavirus - pathogenicity; Biomedical and Life Sciences; Biomedicine; Brief Communication; Cancer Research; Coronavirus Infections - blood; Coronavirus Infections - drug therapy; Coronavirus Infections - immunology; Coronavirus Infections - virology; Coronaviruses; COVID-19; Female; Health aspects; Humans; Immune response; Immunoglobulin G; Immunoglobulin G - blood; Immunoglobulin M; Immunoglobulin M - blood; Infectious Diseases; Male; Metabolic Diseases; Middle Aged; Molecular Medicine; Neurosciences; Pandemics - prevention & control; Physiological aspects; Pneumonia, Viral - blood; Pneumonia, Viral - drug therapy; Pneumonia, Viral - immunology; Pneumonia, Viral - virology; SARS-CoV-2; Seroconversion; Severe acute respiratory syndrome coronavirus 2; Viral antibodies; China